1,2-dimethylhydrazine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of KCTD12 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of KCTD12 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO Kctd12 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of KCTD12 mRNA CTD PMID:29097150 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of KCTD12 mRNA CTD PMID:15289156 17beta-estradiol increases expression ISO KCTD12 (Homo sapiens) 6480464 Estradiol results in increased expression of KCTD12 mRNA CTD PMID:23019147 and PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of KCTD12 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO KCTD12 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of KCTD12 mRNA CTD PMID:30096437 2-methylcholine affects expression ISO KCTD12 (Homo sapiens) 6480464 beta-methylcholine affects the expression of KCTD12 mRNA CTD PMID:21179406 3,3',5-triiodo-L-thyronine decreases expression EXP 6480464 Triiodothyronine results in decreased expression of KCTD12 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of KCTD12 mRNA CTD PMID:16997883 4,4'-sulfonyldiphenol decreases methylation ISO KCTD12 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of KCTD12 gene CTD PMID:31601247 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of KCTD12 mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO KCTD12 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of KCTD12 mRNA CTD PMID:17039268 8-Br-cAMP multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of KCTD12 mRNA CTD PMID:16997883 8-Br-cAMP increases expression ISO KCTD12 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCTD12 mRNA CTD PMID:20147733 8-Br-cAMP decreases expression ISO KCTD12 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KCTD12 mRNA CTD PMID:22079614 all-trans-retinoic acid increases expression ISO KCTD12 (Homo sapiens) 6480464 Tretinoin results in increased expression of KCTD12 mRNA CTD PMID:23724009 aristolochic acid A decreases expression ISO KCTD12 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of KCTD12 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO KCTD12 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to KCTD12 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO KCTD12 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of KCTD12 mRNA CTD PMID:15761015 and PMID:25258189 benzatropine decreases expression ISO KCTD12 (Homo sapiens) 6480464 Benztropine results in decreased expression of KCTD12 protein CTD PMID:34122009 benzo[a]pyrene decreases expression ISO KCTD12 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of KCTD12 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO KCTD12 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of KCTD12 promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of KCTD12 mRNA CTD PMID:22228805 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of KCTD12 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate decreases expression ISO KCTD12 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of KCTD12 protein CTD PMID:31163220 bisphenol A increases expression ISO Kctd12 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of KCTD12 mRNA CTD PMID:29097150 bisphenol A decreases expression ISO KCTD12 (Homo sapiens) 6480464 bisphenol A results in decreased expression of KCTD12 protein CTD PMID:34186270 bisphenol A multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of KCTD12 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KCTD12 mRNA CTD PMID:33221593 bisphenol A decreases expression ISO Kctd12 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of KCTD12 mRNA CTD PMID:30816183 Bisphenol B increases expression ISO KCTD12 (Homo sapiens) 6480464 bisphenol B results in increased expression of KCTD12 protein CTD PMID:34186270 bisphenol F increases expression ISO KCTD12 (Homo sapiens) 6480464 bisphenol F results in increased expression of KCTD12 protein CTD PMID:34186270 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of KCTD12 mRNA CTD PMID:24982889 calcitriol increases expression ISO KCTD12 (Homo sapiens) 6480464 Calcitriol results in increased expression of KCTD12 mRNA CTD PMID:16002434 cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of KCTD12 mRNA CTD PMID:21542829 carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of KCTD12 mRNA CTD PMID:25554681 cisplatin increases expression ISO KCTD12 (Homo sapiens) 6480464 Cisplatin results in increased expression of KCTD12 mRNA CTD PMID:27392435 clozapine decreases expression ISO KCTD12 (Homo sapiens) 6480464 Clozapine results in decreased expression of KCTD12 protein CTD PMID:34122009 cobalt dichloride decreases expression ISO KCTD12 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of KCTD12 mRNA CTD PMID:19320972 copper atom multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KCTD12 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of KCTD12 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO KCTD12 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of KCTD12 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO KCTD12 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of KCTD12 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO KCTD12 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of KCTD12 mRNA CTD PMID:29523930 Cuprizon decreases expression ISO Kctd12 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of KCTD12 mRNA CTD PMID:26577399 cytarabine decreases expression ISO KCTD12 (Homo sapiens) 6480464 Cytarabine results in decreased expression of KCTD12 mRNA CTD PMID:21198554 dexamethasone multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of KCTD12 mRNA CTD PMID:16997883 diarsenic trioxide decreases expression ISO KCTD12 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of KCTD12 mRNA CTD PMID:15761015 and PMID:25258189 dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:26377693 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of KCTD12 mRNA CTD PMID:15289156 dorsomorphin multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of KCTD12 mRNA CTD PMID:15033991 doxorubicin increases expression ISO KCTD12 (Homo sapiens) 6480464 Doxorubicin results in increased expression of KCTD12 mRNA CTD PMID:30031762 entinostat increases expression ISO KCTD12 (Homo sapiens) 6480464 entinostat results in increased expression of KCTD12 mRNA CTD PMID:26272509 entinostat multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KCTD12 protein CTD PMID:23301498 ethanol increases expression ISO KCTD12 (Homo sapiens) 6480464 Ethanol results in increased expression of KCTD12 mRNA CTD PMID:31059573 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of KCTD12 mRNA] CTD PMID:22206623 fulvestrant multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of KCTD12 gene CTD PMID:31601247 gemcitabine decreases expression ISO KCTD12 (Homo sapiens) 6480464 Gemcitabine results in decreased expression of KCTD12 mRNA CTD PMID:17039268 genistein decreases expression EXP 6480464 Genistein results in decreased expression of KCTD12 mRNA CTD PMID:15289156 hexadecanoic acid increases phosphorylation ISO KCTD12 (Homo sapiens) 6480464 Palmitic Acid results in increased phosphorylation of KCTD12 protein CTD PMID:28073184 indole-3-methanol multiple interactions ISO Kctd12 (Rattus norvegicus) 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KCTD12 mRNA CTD PMID:22129741 indometacin decreases expression ISO KCTD12 (Homo sapiens) 6480464 Indomethacin results in decreased expression of KCTD12 mRNA CTD PMID:16984733 isotretinoin increases expression ISO KCTD12 (Homo sapiens) 6480464 Isotretinoin results in increased expression of KCTD12 mRNA CTD PMID:20436886 ivermectin decreases expression ISO KCTD12 (Homo sapiens) 6480464 Ivermectin results in decreased expression of KCTD12 protein CTD PMID:32959892 ketoconazole decreases expression ISO Kctd12 (Rattus norvegicus) 6480464 Ketoconazole results in decreased expression of KCTD12 mRNA CTD PMID:37077353 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of KCTD12 mRNA CTD PMID:27339419 lipopolysaccharide multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KCTD12 mRNA CTD PMID:35811015 mercury dibromide increases expression ISO KCTD12 (Homo sapiens) 6480464 mercuric bromide results in increased expression of KCTD12 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA CTD PMID:27188386 N-methyl-4-phenylpyridinium decreases expression ISO KCTD12 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of KCTD12 mRNA CTD PMID:24810058 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO Kctd12 (Rattus norvegicus) 6480464 Methylnitronitrosoguanidine results in increased expression of KCTD12 mRNA CTD PMID:15120970 N-nitrosodiethylamine multiple interactions ISO Kctd12 (Rattus norvegicus) 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KCTD12 mRNA CTD PMID:22129741 panobinostat multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA CTD PMID:27188386 panobinostat increases expression ISO KCTD12 (Homo sapiens) 6480464 panobinostat results in increased expression of KCTD12 mRNA CTD PMID:26272509 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of KCTD12 mRNA CTD PMID:17562736 paracetamol affects expression ISO KCTD12 (Homo sapiens) 6480464 Acetaminophen affects the expression of KCTD12 mRNA CTD PMID:25458485 pentanal increases expression ISO KCTD12 (Homo sapiens) 6480464 pentanal results in increased expression of KCTD12 mRNA CTD PMID:26079696 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of KCTD12 mRNA CTD PMID:19482888 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of KCTD12 mRNA CTD PMID:23091169 phenobarbital multiple interactions EXP 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of KCTD12 mRNA] CTD PMID:19482888 phenylmercury acetate increases expression ISO KCTD12 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of KCTD12 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of KCTD12 mRNA CTD PMID:17426115 and PMID:18445702 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of KCTD12 mRNA CTD PMID:23811191 pravastatin decreases expression ISO Kctd12 (Rattus norvegicus) 6480464 Pravastatin results in decreased expression of KCTD12 mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of KCTD12 mRNA CTD PMID:27225895 progesterone increases expression ISO KCTD12 (Homo sapiens) 6480464 Progesterone results in increased expression of KCTD12 mRNA CTD PMID:21795739 progesterone increases expression EXP 6480464 Progesterone results in increased expression of KCTD12 mRNA CTD PMID:22238285 protein kinase inhibitor multiple interactions ISO KCTD12 (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of KCTD12 mRNA] CTD PMID:28003376 raloxifene affects expression ISO KCTD12 (Homo sapiens) 6480464 Raloxifene Hydrochloride affects the expression of KCTD12 mRNA CTD PMID:14699072 raloxifene multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of KCTD12 mRNA and [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of KCTD12 mRNA CTD PMID:19059307 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KCTD12 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases expression ISO KCTD12 (Homo sapiens) 6480464 Asbestos and Serpentine results in decreased expression of KCTD12 mRNA CTD PMID:29523930 sodium arsenite multiple interactions ISO KCTD12 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of and affects the splicing of KCTD12 mRNA CTD PMID:25879800 sodium arsenite affects expression ISO KCTD12 (Homo sapiens) 6480464 sodium arsenite affects the expression of KCTD12 mRNA CTD PMID:34032870 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of KCTD12 protein CTD PMID:29044176 sodium arsenite increases expression ISO KCTD12 (Homo sapiens) 6480464 sodium arsenite results in increased expression of KCTD12 mRNA CTD PMID:21281968 and PMID:28595984 sodium dichromate decreases expression ISO KCTD12 (Homo sapiens) 6480464 sodium bichromate results in decreased expression of KCTD12 mRNA CTD PMID:17685462 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of KCTD12 protein CTD PMID:28918527 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of KCTD12 mRNA CTD PMID:21641980 sulforaphane decreases expression ISO KCTD12 (Homo sapiens) 6480464 sulforaphane results in decreased expression of KCTD12 mRNA CTD PMID:31838189 sunitinib decreases expression ISO KCTD12 (Homo sapiens) 6480464 Sunitinib results in decreased expression of KCTD12 mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of KCTD12 mRNA and [Tamoxifen co-treated with ESR2 protein] results in decreased expression of KCTD12 mRNA CTD PMID:19059307 temozolomide decreases expression ISO KCTD12 (Homo sapiens) 6480464 Temozolomide results in decreased expression of KCTD12 mRNA CTD PMID:31758290 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of KCTD12 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of KCTD12 mRNA CTD PMID:27339419 and PMID:31919559 thapsigargin increases expression ISO KCTD12 (Homo sapiens) 6480464 Thapsigargin results in increased expression of KCTD12 mRNA CTD PMID:19442820 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of KCTD12 mRNA CTD PMID:23557971 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of KCTD12 mRNA CTD PMID:29264374 trichostatin A increases expression ISO KCTD12 (Homo sapiens) 6480464 trichostatin A results in increased expression of KCTD12 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA CTD PMID:27188386 triclosan increases expression ISO KCTD12 (Homo sapiens) 6480464 Triclosan results in increased expression of KCTD12 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of KCTD12 mRNA CTD PMID:19042947 triptonide increases expression EXP 6480464 triptonide results in increased expression of KCTD12 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of KCTD12 mRNA CTD PMID:28973697 valproic acid affects expression ISO KCTD12 (Homo sapiens) 6480464 Valproic Acid affects the expression of KCTD12 mRNA CTD PMID:25979313 valproic acid increases expression ISO KCTD12 (Homo sapiens) 6480464 Valproic Acid results in increased expression of KCTD12 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA CTD PMID:27188386 vorinostat increases expression ISO KCTD12 (Homo sapiens) 6480464 vorinostat results in increased expression of KCTD12 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO KCTD12 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD12 mRNA CTD PMID:27188386